Page 108 - Vitamin D and Cancer

4 The Epidemiology of Vitamin D and Cancer Risk 95

49. Ding EL, Mehta S, Fawzi WW, Giovannucci EL (2008) Interaction of estrogen therapy with
calcium and vitamin D supplementation on colorectal cancer risk: Reanalysis of Women’s
Health Initiative randomized trial. Int J Cancer 122:1690–1694
50. Corder EH, Guess HA, Hulka BS et al (1993) Vitamin D and prostate cancer: a prediagnostic
study with stored sera. Cancer Epidemiol Biomarkers Prev 2:467–472
51. Gann PH, Ma J, Hennekens CH, Hollis BW, Haddad JG, Stampfer MJ (1996) Circulating
vitamin D metabolites in relation to subsequent development of prostate cancer. Cancer
Epidemiol Biomarkers Prev 5:121–126
52. Nomura AM, Stemmermann GN, Lee J et al (1998) Serum vitamin D metabolite levels and
the subsequent development of prostate cancer. Cancer Causes Control 9:425–432
53. Platz EA, Leitzmann MF, Hollis BW, Willett WC, Giovannucci E (2004) Plasma 1, 25-dihy-
droxy- and 25-hydroxyvitamin D and subsequent risk of prostate cancer. Cancer Causes
Control 15:255–265
54. Jacobs ET, Giuliano AR, Martinez ME, Hollis BW, Reid ME, Marshall JR (2004) Plasma
levels of 25-hydroxyvitamin D, 1, 25-dihydroxyvitamin D and the risk of prostate cancer.
J Steroid Biochem Mol Biol 89–90:533–537
55. Ahonen MH, Tenkanen L, Teppo L, Hakama M, Tuohimaa P (2000) Prostate cancer risk and
prediagnostic serum 25-hydroxyvitamin D levels (Finland). Cancer Causes Control
11:847–852
56. Tuohimaa P, Tenkanen L, Ahonen M et al (2004) Both high and low levels of blood vitamin
D are associated with a higher prostate cancer risk: a longitudinal, nested case-control study
in the Nordic countries. Int J Cancer 108:104–108
57. Li H, Stampfer MJ, Hollis BW et al (2007) A prospective study of plasma vitamin D metabo-
lites, vitamin D receptor polymorphisms, and prostate cancer. PLoS Med 4:e103
58. Ahn J, Peters U, Albanes D et al (2008) Serum vitamin D concentration and prostate cancer
risk: a nested case-control study. J Natl Cancer Inst 100:796–804
59. Giovannucci E, Rimm EB, Wolk A et al (1998) Calcium and fructose intake in relation to risk
of prostate cancer. Cancer Res 58:442–447
60. Chan JM, Giovannucci E, Andersson SO, Yuen J, Adami HO, Wolk A (1998) Dairy products,
calcium, phosphorous, vitamin D, and risk of prostate cancer. Cancer Causes Control
9:559–566
61. Chan JM, Pietinen P, Virtanen M, Malila N, Tangrea J (2000) Diet and prostate cancer risk in
a cohort of smokers, with a specific focus on calcium and phosphorus (Finland). Cancer
Causes Control 11:859–867
62. Kristal AR, Cohen JH, Qu P, Stanford JL (2002) Associations of energy, fat, calcium, and
vitamin D with prostate cancer risk. Cancer Epidemiol Biomarkers Prev 11:719–725
63. John EM, Schwartz GG, Koo J, Van Den Berg D, Ingles SA (2005) Sun exposure, vitamin D
receptor gene polymorphisms, and risk of advanced prostate cancer. Cancer Res
65:5470–5479
64. John EM, Koo J, Schwartz GG (2007) Sun exposure and prostate cancer risk: evidence for a
protective effect of early-life exposure. Cancer Epidemiol Biomarkers Prev 16:1283–1286
65. Luscombe CJ, Fryer AA, French ME et al (2001) Exposure to ultraviolet radiation: associa-
tion with susceptibility and age at presentation with prostate cancer. Lancet 358:641–642
66. Bodiwala D, Luscombe CJ, French ME et al (2003) Associations between prostate cancer
susceptibility and parameters of exposure to ultraviolet radiation. Cancer Lett 200:141–148
67. Rukin N, Blagojevic M, Luscombe CJ et al (2007) Associations between timing of exposure
to ultraviolet radiation, T-stage and survival in prostate cancer. Cancer Detect Prev
31:443–449
68. Bertone-Johnson E, Chen WY, Holick MF et al (2005) Plasma 25-hydroxyvitamin D and 1,
25-dihydroxyvitamin D and risk of breast cancer. Cancer Epidemiol Biomarkers Prev 14:
1991–1997
69. Freedman DM, Chang SC, Falk RT et al (2008) Serum levels of vitamin D metabolites and
breast cancer risk in the prostate, lung, colorectal, and ovarian cancer screening trial. Cancer
Epidemiol Biomarkers Prev 17:889–894